戻る Agenda
S08 : First-in-Global, First from Japan: Current Status and Future Prospects of First-In-Human Trials in Japan
Session Chair(s)
Masako Nakano, MD, PhD
Executive Medical Director
MORRIS Inc., Japan
Speaker(s)
Naruaki Imoto
Pharmaceticals and Medical Devices Agency (PMDA), Japan
Mika Sato
Novartis Pharma K.K., Japan
Biomedical Research,Head of Translational Medicine Japan
Toshio Shimizu, MD, PhD
Kansai Medical University Hospital, Japan
Professor, Department of New Experimental Therapeutics and Early Phase 1 Drug De
Tatsuya Yoshihara
SOUSEIKAI Fukuoka Mirai Hospital, Japan
Deputy Director Clinical Research Center